Acute Myeloid Leukemias
Oncology·MeSH: Leukemia, Myeloid, Acute
Prevalence
6.0 / 100K
Incidence
4.3 / 100K/yr
7 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Acute Myeloid Leukemias?
BioSniper tracks 7 drugs in development for Acute Myeloid Leukemias across 2 companies.
How many clinical trials target Acute Myeloid Leukemias?
There are 2 clinical trials targeting Acute Myeloid Leukemias tracked by BioSniper.
What is the prevalence of Acute Myeloid Leukemias?
The estimated prevalence of Acute Myeloid Leukemias is approximately 6.0 per 100,000 population.
Deep-dive into Acute Myeloid Leukemias
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis